Waters has welcomed the Future Fuels Institute at the Florida State University into its Centres of Innovation Programme, the first such Centre of Innovation in the field of energy research.
Waters has welcomed the Future Fuels Institute at the Florida State University into its Centres of Innovation Programme, the first such Centre of Innovation in the field of energy research. The institute pursues collaborative activities in fundamental science, enabling technologies and applied knowledge in the areas of fuels sciences and technology to promote education, outreach and training.
Director of the institute, Dr Chang Samuel Hsu, is pioneering research into the development of fuels from fossil and renewable energy sources to meet future global demands for energy. He is focusing on research into biofuels derived from natural and renewable source materials. These include solid biomass such as wood, sawdust, agricultural wastes and non-food crops converted into ethanol, biobutanols, gasoline, jet fuels and diesels. “Everyday life depends on ready sources of energy and fuels. Sustainability of energy supplies and harmful emission reduction for dealing with climate change are central themes. We established the Future Fuels Institute to address these pressing issues and needs,” he commented.
Dr Hsu has published three books, eight book chapters, 13 patents and over 120 other publications on topics such as the chemistry of diesel fuels, analytical advances for hydrocarbon research and practical advances in petroleum processing.
Tim Riley, PhD, Vice President of Strategic Innovation, Waters Division, and Programme Director of Waters Centres of Innovation programme, said, “Dr Hsu is one of the world’s most accomplished researchers in the field of petroleum research and his contributions to the field are well recognized. It gives us great pleasure to recognize the Future Fuels Institute and support its ongoing research.”
For more information visit ref="http://www.waters.com">www.waters.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.